Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MIST Milestone Pharmaceuticals Inc.

盘后交易 11-19 18:20:26 EST

1.74

+0.04

+2.35%

盘后1.74

+0.000.00%

17:25 EST

最高1.77	最低1.68	成交量10.41万
今开1.69	昨收1.70	日振幅5.18%
总市值9,279万	流通市值9,195万	总股本5,333万
成交额17.92万	换手率0.20%	流通股本5,285万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MIST","market":"US","secType":"STK","nameCN":"Milestone Pharmaceuticals Inc.","latestPrice":1.74,"timestamp":1732050000000,"preClose":1.7,"halted":0,"volume":104119,"hourTrading":{"tag":"盘后","latestPrice":1.74,"preClose":1.74,"latestTime":"17:25 EST","volume":8109,"amount":14109.66,"timestamp":1732055144138},"delay":0,"floatShares":52845000,"shares":53327908,"eps":-0.956922,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.04,"latestTime":"11-19 18:20:26 EST","open":1.69,"high":1.77,"low":1.682,"amount":179241.2333284,"amplitude":0.051765,"askPrice":1.82,"askSize":800,"bidPrice":1.69,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.956922,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732064400000},"adr":0,"listingDate":1557374400000,"adjPreClose":1.7,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.7,"preClose":1.7,"latestTime":"08:02 EST","volume":4,"amount":6.8,"timestamp":1732021330230},"postHourTrading":{"tag":"盘后","latestPrice":1.74,"preClose":1.74,"latestTime":"17:25 EST","volume":8109,"amount":14109.66,"timestamp":1732055144138},"volumeRatio":0.242168,"impliedVol":0.8828,"impliedVolPercentile":0.3016},"requestUrl":"/m/hq/s/MIST/wiki","defaultTab":"wiki","newsList":[{"id":"2484155369","title":"Milestone Pharmaceuticals Inc.2024财年第三财季实现净利润-9.44百万美元，同比增加37.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484155369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484155369?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010420,"startTime":"0","endTime":"0","summary":"11月19日，Milestone Pharmaceuticals Inc.公布财报，公告显示公司2024财年第三财季净利润为-9.44百万美元，同比增加37.40%；其中营业收入为0.00美元，每股基本收益为-0.14美元。机构评级：截至2024年11月19日，当前有5家机构对Milestone Pharmaceuticals Inc.目标价做出预测，其中目标均价为10.00美元，其中最低目标价为2.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180040abcedeef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180040abcedeef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST"],"gpt_icon":0},{"id":"2483881219","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘股价大跌5.88%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483881219?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:32","pubTimestamp":1731508360,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时32分，Milestone Pharmaceuticals Inc.股票出现异动，股价大幅跳水5.88%。截至发稿，该股报1.76美元/股，成交量9795股，换手率0.02%，振幅1.60%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223240971a6477&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223240971a6477&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2478481602","title":"Milestone Pharmaceuticals Inc.盘中异动 急速拉升6.12%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478481602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478481602?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:32","pubTimestamp":1730122368,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时32分，Milestone Pharmaceuticals Inc.股票出现异动，股价大幅上涨6.12%。截至发稿，该股报1.53美元/股，成交量1201股，换手率0.00%，振幅0.00%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213248971a2a1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213248971a2a1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2465614272","title":"BUZZ--美国股票走势-DocuSign、美国住宅建筑商、德克萨斯资本银行","url":"https://stock-news.laohu8.com/highlight/detail?id=2465614272","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465614272?lang=zh_cn&edition=full","pubTime":"2024-09-07 00:10","pubTimestamp":1725639004,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月6日 - 华尔街主要股指周五下跌，因为一份至关重要的就业报告几乎没有消除美联储本月晚些时候会议上预计的降息幅度的不确定性。美东时间11:32，道琼斯工业平均指数  为!标普500指数  下跌1.44%，报5424.4点；纳斯达克综合指数  下跌2.17%，报16756.227点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABM","AMRX","3NVD.UK","CVX","QLD","TOL","CORZ","EXPE","ALB","AVB","SMAR","TQQQ","L","2NVD.UK","DJX","COIN","MTH","IOT","INTC",".DJI","UDOW","VTLE","BKNG","BOWL","MBLY","DOG","JPM","XOM","AVGO","DOCU","DPZ","SWBI","ALTM","SQQQ","MIST","MNQmain","TCBI","QCOM","CLX","HUT","BUZZ",".IXIC","LU","NVDA","PHM","SMCI","CRGY","NEM"],"gpt_icon":1},{"id":"2459590477","title":"Milestone Pharmaceuticals Inc.2024财年第二财季实现净利润-9.36百万美元，同比增加41.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459590477","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459590477?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:03","pubTimestamp":1723737803,"startTime":"0","endTime":"0","summary":"8月16日，Milestone Pharmaceuticals Inc.公布财报，公告显示公司2024财年第二财季净利润为-9.36百万美元，同比增加41.65%；其中营业收入为0.00美元，每股基本收益为-0.14美元。机构评级：截至2024年8月16日，当前有4家机构对Milestone Pharmaceuticals Inc.目标价做出预测，其中目标均价为10.25美元，其中最低目标价为2.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000335959be6fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000335959be6fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST"],"gpt_icon":0},{"id":"2457213368","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457213368","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457213368?lang=zh_cn&edition=full","pubTime":"2024-08-08 00:05","pubTimestamp":1723046713,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日00时05分，Milestone Pharmaceuticals Inc.股票出现波动，股价大幅下跌5.22%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.61%。其相关个股中，Aditxt, Inc.、G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为4689.15%、1168.30%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、47.31%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808000513aefdbd75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808000513aefdbd75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2452456168","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘股价大跌6.06%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452456168","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452456168?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:19","pubTimestamp":1721225987,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时19分，Milestone Pharmaceuticals Inc.股票出现异动，股价快速下跌6.06%。截至发稿，该股报1.55美元/股，成交量19.2641万股，换手率0.36%，振幅7.88%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.08%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717221947af92cb3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717221947af92cb3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2452912117","title":"Milestone Pharmaceuticals Inc.盘中异动 临近午盘大幅拉升5.36%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452912117","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452912117?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:58","pubTimestamp":1721145506,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时58分，Milestone Pharmaceuticals Inc.股票出现波动，股价大幅拉升5.36%。截至发稿，该股报1.67美元/股，成交量3.3628万股，换手率0.06%，振幅2.59%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716235826aef9f798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716235826aef9f798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2450506074","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大涨6.62%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450506074","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450506074?lang=zh_cn&edition=full","pubTime":"2024-07-10 03:12","pubTimestamp":1720552367,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日03时12分，Milestone Pharmaceuticals Inc.股票出现波动，股价大幅拉升6.62%。截至发稿，该股报1.45美元/股，成交量12.5588万股，换手率0.24%，振幅6.62%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.85%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100312489681b35b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100312489681b35b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2439571000","title":"Milestone Pharmaceuticals Inc.盘中异动 临近午盘快速跳水6.05%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439571000","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439571000?lang=zh_cn&edition=full","pubTime":"2024-05-29 23:32","pubTimestamp":1716996732,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日23时32分，Milestone Pharmaceuticals Inc.股票出现异动，股价快速跳水6.05%。截至发稿，该股报1.55美元/股，成交量31.6433万股，换手率0.59%，振幅8.48%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.03%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529233212aef2593e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529233212aef2593e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.milestonepharma.com","stockEarnings":[{"period":"1week","weight":-0.1237},{"period":"1month","weight":0.1409},{"period":"3month","weight":0.2409},{"period":"6month","weight":-0.0286},{"period":"1year","weight":-0.2273},{"period":"ytd","weight":0.018}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Milestone Pharmaceuticals Inc.于2003年根据魁北克省法律注册成立。该公司是一家专注于心血管创新药物开发和商业化的生物制药公司。公司主导候选产品曲立帕米是一种新型强效钙通道阻滞剂，他们将其设计为一种快速起效的鼻腔喷雾剂，供患者自行给药。该公司正在开发用于治疗特定心律失常的曲立帕米，其主要适应症是治疗阵发性室上性心动过速，或PSVT，随后的适应症是治疗具有快速心室率的心房颤动，或AFIB-RVR。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.084125},{"month":2,"riseRate":0.2,"avgChangeRate":-0.107485},{"month":3,"riseRate":0.6,"avgChangeRate":-0.097718},{"month":4,"riseRate":0.6,"avgChangeRate":0.105379},{"month":5,"riseRate":0.6,"avgChangeRate":-0.015932},{"month":6,"riseRate":0.5,"avgChangeRate":0.019419},{"month":7,"riseRate":0.833333,"avgChangeRate":0.228377},{"month":8,"riseRate":0.5,"avgChangeRate":0.054646},{"month":9,"riseRate":0.5,"avgChangeRate":-0.000002},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.145809},{"month":11,"riseRate":0.5,"avgChangeRate":0.078561},{"month":12,"riseRate":0.2,"avgChangeRate":-0.109404}],"exchange":"NASDAQ","name":"Milestone Pharmaceuticals Inc.","nameEN":"Milestone Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Milestone Pharmaceuticals Inc.(MIST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Milestone Pharmaceuticals Inc.,MIST,Milestone Pharmaceuticals Inc.股票,Milestone Pharmaceuticals Inc.股票老虎,Milestone Pharmaceuticals Inc.股票老虎国际,Milestone Pharmaceuticals Inc.行情,Milestone Pharmaceuticals Inc.股票行情,Milestone Pharmaceuticals Inc.股价,Milestone Pharmaceuticals Inc.股市,Milestone Pharmaceuticals Inc.股票价格,Milestone Pharmaceuticals Inc.股票交易,Milestone Pharmaceuticals Inc.股票购买,Milestone Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Milestone Pharmaceuticals Inc.(MIST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}